HAVE OUR BACKS
×
Sign Up
Already Registered?
face
lock_outline
THE FACTS
BIO
BIO
VOTES
VOTES
POSITIONS
POSITIONS
RATINGS
RATINGS
SPEECHES
SPEECHES
FUNDING
FUNDING
Please have our backs
No Thank You
Kamala Harris' Public Statements on Issue: Drugs
Office:
Vice President
, Democratic President of the Senate
On The Ballot:
Running, Democratic for
President with
Tim Walz
Track This Politician
Current Issue:
Drugs
Select Issue
All
Abortion
Agriculture and Food
Animals and Wildlife
Arts, Entertainment, and History
Business and Consumers
Campaign Finance
Civil Liberties and Civil Rights
Constitution
Criminal Justice
Death Penalty
Defense
Drugs
Economy and Fiscal
Education
Elections
Employment and Affirmative Action
Energy
Entitlements and the Safety Net
Environment
Executive Branch
Family
Federal, State and Local Relations
Finance and Banking
Food Processing and Sales
Foreign Affairs
Foreign Aid
Gambling and Gaming
Government Budget and Spending
Government Operations
Guns
Health Insurance
Health and Health Care
Higher Education
Housing and Property
Immigration
Indigenous Peoples
Infrastructure
Judicial Branch
K-12 Education
Labor Unions
Legal
Legislative Branch
Marijuana
Marriage
Military Personnel
Minors and Children
Monetary Policy
National Security
Natural Resources
Oil and Gas
Religion
Reproduction
Science
Senior Citizens
Sexual Orientation and Gender Identity
Stem Cell Research
Taxes
Technology and Communication
Trade
Transportation
Unemployed and Low-Income
Veterans
Women
Current Speech Type:
Letter
Select Speech Type
All
Debate
Executive Order
Floor Speech
Hearing
Interview
Issue Position
Letter
News Article
Op-Ed
Other
Pledge
Press Conference
Press Release
Social Media
Speech
Statement
Date Range
Start Date
End Date
Apply
Keyword Search
close
Reset Search
attach_money
Who is funding Harris?
Date
Title
05/22/2020
Letter to Scott Gast, Deputy Counsel to the President - Menendez, Warren, Colleagues Request Newly Appointed "Therapeutics Czar" to Divest from Financial Interest, Resign to Boards of any Pharmaceutical, Medical and Biotech Companies
05/19/2020
Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package
04/16/2020
Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic
12/11/2019
Letter to the Hon. Alex Azar, Secretary of the U.S. Department of Health and Human Services, the Hon. Uttam Dhillon, Acting Admin. of the U.S. Drug Enforcement Administration, and the Hon. James Carroll, Dir. of the Office of National Drug Control Policy - Harris, Senators Request Update from Federal Agencies on Progress Towards Issuing Long-Delayed Licensing of Marijuana Manufacturing for Research Purposes
10/29/2019
Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes
10/11/2019
Letter to K.C. Crosthwaite, CEO of Juul - Senator Hassan, Colleagues Call on Juul to End Unfair Forced Arbitration Agreements That Restrict Americans' Access to Justice
07/30/2019
Letter to Michael Pompeo, Secretary of State - Harris, Feinstein, Democrats Reiterate Concerns about Trump Admin's Lack of Strategy for Central America
07/11/2019
Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Durbin, Lee, Senators Press HHS About Public Health Impact Of "Fentanyl-Related" Scheduling
06/18/2019
Letter to the Hon. William Barr, Attorney General of the United States, and the Hon. Kevin McAleenan, Acting Secretary of Homeland Security - Senators Call on DOJ and DHS to Stop Implementation of Guidance Denying Citizenship Over Cannabis-related Activities
08/30/2018
Letter to the Hon. Jeff Sessions, Attorney General - Hatch, Harris Follow Up with Sessions, DOJ Regarding Medical Marijuana Research
04/18/2018
Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Stabenow, Peters Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
04/12/2018
Letter to the Hon. Jess Sessions, Attorney General of the United States - Hatch, Harris Call on Sessions, DOJ to Stop Blocking Medical Marijuana Research
03/07/2018
Letter to the Hon Thad Cochran, Chairman of the Committee of Appropriations, and the Hon Patrick Leahy, Ranking Member of the Committee on Appropriations - Senator Cantwell Pushes for Additional Funding to Combat Opioid Crisis, Support Treatment Efforts in Indian Country
03/05/2018
Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon. Roy Blunt, Chairman of the Subcommittee on Labor, Health and Human Services, and Education, and the Hon. Patty Murray, Ranking Member of the Subcommittee on Labor, Health and Human Services, and Education - Advocate for Resources to Combat Opioid Crisis in Foster Care System
02/12/2018
Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Respect State Marijuana Laws
10/25/2017
Letter to President Donald Trump - Senators Call on President to Allow Government to Negotiate Lower Prices for Naloxone, a Life-Saving Opioid Overdose Reversal Drug
10/25/2017
Letter to President Donald J. Trump - Allow Government to Negotiate Lower Prices for Naloxone
10/20/2017
Letter to Eric Hargan, Acting Secretary of Health and Human Services, Robert Patterson, Acting Administrator of Drug Enforcement Administration - Ensuring Patient Access and Effective Drug Enforcement Act
07/19/2017
Letter to Richard Baum, Acting Director Office of National Drug Control Policy - Deliver a Strategy to Battle Opioid Addiction
05/17/2017
Letter to the Honorable Roy Blunt and Patty Murray, Chairman and Ranking Member of Senate Appropriations Subcommittee on Labor, HHS, and Education, and the Honorable Thad Cochran and Patrick Leahy, Chairman and Vice-Chairman of Senate Appropriations Committee - Increase Funding to Combat Opioid Epidemic
attach_money
Who is funding Harris?
clear
Log in
face
lock_outline
face
person
person_outline
email
lock
lock_outline
Enter the same password as above, for verification.
arrow_upward